NewLead (NEWL) Completes Sale of Four LR1 Tankers, One Panamax Vessel
Tweet Send to a Friend
NewLead Holdings Ltd. (Nasdaq: NEWL) announced the completion of the sale of the four LR1 product tankers and one Panamax dry bulk vessel, the 1990-built "Newlead Esmeralda". The sale of these vessels was conducted as part of the Company's overall financial restructuring plan.
Following the successful completion of sale of the five vessels, the net sales proceeds have been applied in full satisfaction of all liabilities under the governing loan agreements. NewLead's overall indebtedness decreased by an aggregate of approximately $159.0 million after these sales, of which a decrease of $147.9 million resulted from the sale of the four LR1 product tankers and a decrease of $11.1 million resulted from the sale of the "Newlead Esmeralda" for total sale proceeds of $12.0 million out of which $0.9 million will be used to satisfy a substantial part of the vessel's trade debt.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Following the successful completion of sale of the five vessels, the net sales proceeds have been applied in full satisfaction of all liabilities under the governing loan agreements. NewLead's overall indebtedness decreased by an aggregate of approximately $159.0 million after these sales, of which a decrease of $147.9 million resulted from the sale of the four LR1 product tankers and a decrease of $11.1 million resulted from the sale of the "Newlead Esmeralda" for total sale proceeds of $12.0 million out of which $0.9 million will be used to satisfy a substantial part of the vessel's trade debt.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NewLead (NEWL) Receives Nasdaq Notice of Non-Compliance Over Late 20-F
- Tempur-Pedic (TPX) is Now 'Tempur Sealy International'
- Echo Pharma Lowers Acceptance Threshold in Elan (ELN) Bid to 50%
Create E-mail Alert Related Categories
Corporate News, Mergers and Acquisitions
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
